nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—autonomic nervous system—alcohol dependence	0.0374	0.171	CbGeAlD
Rescinnamine—Tingling sensation—Disulfiram—alcohol dependence	0.0233	0.0339	CcSEcCtD
Rescinnamine—ACE—nerve—alcohol dependence	0.021	0.0961	CbGeAlD
Rescinnamine—Skin infection—Citalopram—alcohol dependence	0.0183	0.0266	CcSEcCtD
Rescinnamine—Sunburn—Citalopram—alcohol dependence	0.0183	0.0266	CcSEcCtD
Rescinnamine—Taste metallic—Citalopram—alcohol dependence	0.0174	0.0253	CcSEcCtD
Rescinnamine—Psoriasis—Acamprosate—alcohol dependence	0.0147	0.0213	CcSEcCtD
Rescinnamine—Hypertrichosis—Citalopram—alcohol dependence	0.0145	0.0212	CcSEcCtD
Rescinnamine—Hypothyroidism—Acamprosate—alcohol dependence	0.0144	0.0209	CcSEcCtD
Rescinnamine—SLC18A2—brainstem—alcohol dependence	0.0132	0.0604	CbGeAlD
Rescinnamine—Seborrhoeic dermatitis—Naltrexone—alcohol dependence	0.0128	0.0186	CcSEcCtD
Rescinnamine—Skin irritation—Citalopram—alcohol dependence	0.0128	0.0186	CcSEcCtD
Rescinnamine—SLC18A2—forebrain—alcohol dependence	0.0128	0.0583	CbGeAlD
Rescinnamine—Abscess—Acamprosate—alcohol dependence	0.0116	0.017	CcSEcCtD
Rescinnamine—Bursitis—Citalopram—alcohol dependence	0.0114	0.0166	CcSEcCtD
Rescinnamine—Eyelid oedema—Citalopram—alcohol dependence	0.0109	0.0159	CcSEcCtD
Rescinnamine—Accidental injury—Acamprosate—alcohol dependence	0.0104	0.0152	CcSEcCtD
Rescinnamine—Cough increased—Acamprosate—alcohol dependence	0.0101	0.0147	CcSEcCtD
Rescinnamine—Osteoporosis—Citalopram—alcohol dependence	0.00985	0.0144	CcSEcCtD
Rescinnamine—Hypoaesthesia—Disulfiram—alcohol dependence	0.00935	0.0136	CcSEcCtD
Rescinnamine—Vaginal inflammation—Acamprosate—alcohol dependence	0.00922	0.0134	CcSEcCtD
Rescinnamine—SLC18A2—digestive system—alcohol dependence	0.00895	0.0409	CbGeAlD
Rescinnamine—Psoriasis—Citalopram—alcohol dependence	0.00879	0.0128	CcSEcCtD
Rescinnamine—ACE—forebrain—alcohol dependence	0.00871	0.0398	CbGeAlD
Rescinnamine—Vaginal infection—Acamprosate—alcohol dependence	0.0087	0.0127	CcSEcCtD
Rescinnamine—Hypothyroidism—Citalopram—alcohol dependence	0.00861	0.0125	CcSEcCtD
Rescinnamine—SLC18A2—blood—alcohol dependence	0.00853	0.039	CbGeAlD
Rescinnamine—Tooth disorder—Citalopram—alcohol dependence	0.00852	0.0124	CcSEcCtD
Rescinnamine—Yohimbine—HTR1B—alcohol dependence	0.00849	0.349	CrCbGaD
Rescinnamine—SLC18A2—midbrain—alcohol dependence	0.00842	0.0385	CbGeAlD
Rescinnamine—SLC18A2—endocrine gland—alcohol dependence	0.0074	0.0338	CbGeAlD
Rescinnamine—ACE—cardiovascular system—alcohol dependence	0.00736	0.0337	CbGeAlD
Rescinnamine—Herpes zoster—Citalopram—alcohol dependence	0.00734	0.0107	CcSEcCtD
Rescinnamine—Injury—Acamprosate—alcohol dependence	0.00728	0.0106	CcSEcCtD
Rescinnamine—SLC18A2—testis—alcohol dependence	0.00705	0.0322	CbGeAlD
Rescinnamine—Gingivitis—Citalopram—alcohol dependence	0.00704	0.0102	CcSEcCtD
Rescinnamine—Dermatitis bullous—Acamprosate—alcohol dependence	0.007	0.0102	CcSEcCtD
Rescinnamine—Abscess—Citalopram—alcohol dependence	0.00698	0.0102	CcSEcCtD
Rescinnamine—SLC18A2—nervous system—alcohol dependence	0.00692	0.0316	CbGeAlD
Rescinnamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—alcohol dependence	0.0069	0.0983	CbGpPWpGaD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD4—alcohol dependence	0.00672	0.0957	CbGpPWpGaD
Rescinnamine—ACE—gonad—alcohol dependence	0.00668	0.0305	CbGeAlD
Rescinnamine—SLC18A2—liver—alcohol dependence	0.00667	0.0305	CbGeAlD
Rescinnamine—SLC18A2—central nervous system—alcohol dependence	0.00666	0.0305	CbGeAlD
Rescinnamine—Endocrine disorder—Citalopram—alcohol dependence	0.00666	0.0097	CcSEcCtD
Rescinnamine—SLC18A2—cerebellum—alcohol dependence	0.00651	0.0298	CbGeAlD
Rescinnamine—Eye irritation—Citalopram—alcohol dependence	0.00647	0.00942	CcSEcCtD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD2—alcohol dependence	0.00626	0.0891	CbGpPWpGaD
Rescinnamine—Accidental injury—Citalopram—alcohol dependence	0.00624	0.00909	CcSEcCtD
Rescinnamine—Skin discolouration—Citalopram—alcohol dependence	0.00612	0.00891	CcSEcCtD
Rescinnamine—ACE—digestive system—alcohol dependence	0.00611	0.0279	CbGeAlD
Rescinnamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—alcohol dependence	0.00608	0.0866	CbGpPWpGaD
Rescinnamine—Paraesthesia—Disulfiram—alcohol dependence	0.00599	0.00873	CcSEcCtD
Rescinnamine—Gastritis—Acamprosate—alcohol dependence	0.00592	0.00862	CcSEcCtD
Rescinnamine—ACE—blood—alcohol dependence	0.00582	0.0266	CbGeAlD
Rescinnamine—Influenza—Acamprosate—alcohol dependence	0.00578	0.00842	CcSEcCtD
Rescinnamine—Yohimbine—SLC6A4—alcohol dependence	0.00574	0.236	CrCbGaD
Rescinnamine—Pain—Disulfiram—alcohol dependence	0.00571	0.00831	CcSEcCtD
Rescinnamine—Yohimbine—DRD2—alcohol dependence	0.00571	0.234	CrCbGaD
Rescinnamine—Angina pectoris—Acamprosate—alcohol dependence	0.00563	0.0082	CcSEcCtD
Rescinnamine—Bronchitis—Acamprosate—alcohol dependence	0.00556	0.0081	CcSEcCtD
Rescinnamine—Vaginal inflammation—Citalopram—alcohol dependence	0.00552	0.00804	CcSEcCtD
Rescinnamine—Influenza—Naltrexone—alcohol dependence	0.00547	0.00797	CcSEcCtD
Rescinnamine—Dermatitis contact—Citalopram—alcohol dependence	0.00546	0.00795	CcSEcCtD
Rescinnamine—Angina pectoris—Naltrexone—alcohol dependence	0.00533	0.00776	CcSEcCtD
Rescinnamine—SLC18A2—brain—alcohol dependence	0.00529	0.0242	CbGeAlD
Rescinnamine—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00528	0.00768	CcSEcCtD
Rescinnamine—Bronchitis—Naltrexone—alcohol dependence	0.00526	0.00766	CcSEcCtD
Rescinnamine—Vaginal infection—Citalopram—alcohol dependence	0.00522	0.00759	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00508	0.0074	CcSEcCtD
Rescinnamine—Myocardial infarction—Acamprosate—alcohol dependence	0.00505	0.00736	CcSEcCtD
Rescinnamine—ACE—endocrine gland—alcohol dependence	0.00505	0.0231	CbGeAlD
Rescinnamine—Urinary tract infection—Acamprosate—alcohol dependence	0.00501	0.0073	CcSEcCtD
Rescinnamine—Hypertonia—Citalopram—alcohol dependence	0.00484	0.00705	CcSEcCtD
Rescinnamine—ACE—testis—alcohol dependence	0.00482	0.022	CbGeAlD
Rescinnamine—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00481	0.007	CcSEcCtD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—SLC6A3—alcohol dependence	0.00479	0.0682	CbGpPWpGaD
Rescinnamine—SLC18A2—Amine compound SLC transporters—SLC6A3—alcohol dependence	0.00479	0.0682	CbGpPWpGaD
Rescinnamine—Myocardial infarction—Naltrexone—alcohol dependence	0.00478	0.00696	CcSEcCtD
Rescinnamine—Conjunctivitis—Naltrexone—alcohol dependence	0.00474	0.0069	CcSEcCtD
Rescinnamine—Urinary tract infection—Naltrexone—alcohol dependence	0.00474	0.0069	CcSEcCtD
Rescinnamine—ACE—nervous system—alcohol dependence	0.00473	0.0216	CbGeAlD
Rescinnamine—Rhinitis—Acamprosate—alcohol dependence	0.00464	0.00676	CcSEcCtD
Rescinnamine—Hypoaesthesia—Acamprosate—alcohol dependence	0.0046	0.0067	CcSEcCtD
Rescinnamine—Pharyngitis—Acamprosate—alcohol dependence	0.00459	0.00669	CcSEcCtD
Rescinnamine—Sinusitis—Naltrexone—alcohol dependence	0.00458	0.00666	CcSEcCtD
Rescinnamine—ACE—liver—alcohol dependence	0.00455	0.0208	CbGeAlD
Rescinnamine—ACE—central nervous system—alcohol dependence	0.00455	0.0208	CbGeAlD
Rescinnamine—Dizziness—Disulfiram—alcohol dependence	0.00441	0.00643	CcSEcCtD
Rescinnamine—Yohimbine—HTR2A—alcohol dependence	0.00441	0.181	CrCbGaD
Rescinnamine—Injury—Citalopram—alcohol dependence	0.00436	0.00635	CcSEcCtD
Rescinnamine—Pharyngitis—Naltrexone—alcohol dependence	0.00435	0.00633	CcSEcCtD
Rescinnamine—Rash—Disulfiram—alcohol dependence	0.00421	0.00613	CcSEcCtD
Rescinnamine—Dermatitis bullous—Citalopram—alcohol dependence	0.0042	0.00611	CcSEcCtD
Rescinnamine—Headache—Disulfiram—alcohol dependence	0.00418	0.00609	CcSEcCtD
Rescinnamine—Dysgeusia—Acamprosate—alcohol dependence	0.00394	0.00574	CcSEcCtD
Rescinnamine—Back pain—Acamprosate—alcohol dependence	0.0039	0.00567	CcSEcCtD
Rescinnamine—Dysgeusia—Naltrexone—alcohol dependence	0.00373	0.00543	CcSEcCtD
Rescinnamine—Back pain—Naltrexone—alcohol dependence	0.00369	0.00537	CcSEcCtD
Rescinnamine—ACE—brain—alcohol dependence	0.00361	0.0165	CbGeAlD
Rescinnamine—Gastritis—Citalopram—alcohol dependence	0.00355	0.00517	CcSEcCtD
Rescinnamine—Cough—Acamprosate—alcohol dependence	0.00352	0.00512	CcSEcCtD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—alcohol dependence	0.00351	0.05	CbGpPWpGaD
Rescinnamine—Hypertension—Acamprosate—alcohol dependence	0.00348	0.00506	CcSEcCtD
Rescinnamine—Influenza—Citalopram—alcohol dependence	0.00347	0.00505	CcSEcCtD
Rescinnamine—Myalgia—Acamprosate—alcohol dependence	0.00343	0.00499	CcSEcCtD
Rescinnamine—Discomfort—Acamprosate—alcohol dependence	0.00339	0.00493	CcSEcCtD
Rescinnamine—Angina pectoris—Citalopram—alcohol dependence	0.00338	0.00492	CcSEcCtD
Rescinnamine—Bronchitis—Citalopram—alcohol dependence	0.00333	0.00485	CcSEcCtD
Rescinnamine—Cough—Naltrexone—alcohol dependence	0.00333	0.00484	CcSEcCtD
Rescinnamine—Hypertension—Naltrexone—alcohol dependence	0.00329	0.00479	CcSEcCtD
Rescinnamine—Infection—Acamprosate—alcohol dependence	0.00327	0.00476	CcSEcCtD
Rescinnamine—Myalgia—Naltrexone—alcohol dependence	0.00324	0.00473	CcSEcCtD
Rescinnamine—Discomfort—Naltrexone—alcohol dependence	0.00321	0.00467	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Citalopram—alcohol dependence	0.00316	0.00461	CcSEcCtD
Rescinnamine—Oedema—Naltrexone—alcohol dependence	0.00311	0.00453	CcSEcCtD
Rescinnamine—Infection—Naltrexone—alcohol dependence	0.00309	0.0045	CcSEcCtD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—MAOA—alcohol dependence	0.00309	0.044	CbGpPWpGaD
Rescinnamine—Acute coronary syndrome—Citalopram—alcohol dependence	0.00305	0.00444	CcSEcCtD
Rescinnamine—Myocardial infarction—Citalopram—alcohol dependence	0.00303	0.00441	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.00302	0.043	CbGpPWpGaD
Rescinnamine—Conjunctivitis—Citalopram—alcohol dependence	0.003	0.00437	CcSEcCtD
Rescinnamine—Urinary tract infection—Citalopram—alcohol dependence	0.003	0.00437	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.003	0.00436	CcSEcCtD
Rescinnamine—Insomnia—Acamprosate—alcohol dependence	0.00297	0.00433	CcSEcCtD
Rescinnamine—Paraesthesia—Acamprosate—alcohol dependence	0.00295	0.0043	CcSEcCtD
Rescinnamine—Sinusitis—Citalopram—alcohol dependence	0.0029	0.00422	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00283	0.00413	CcSEcCtD
Rescinnamine—Insomnia—Naltrexone—alcohol dependence	0.00281	0.0041	CcSEcCtD
Rescinnamine—Constipation—Acamprosate—alcohol dependence	0.00281	0.00409	CcSEcCtD
Rescinnamine—Pain—Acamprosate—alcohol dependence	0.00281	0.00409	CcSEcCtD
Rescinnamine—Paraesthesia—Naltrexone—alcohol dependence	0.00279	0.00407	CcSEcCtD
Rescinnamine—Rhinitis—Citalopram—alcohol dependence	0.00278	0.00405	CcSEcCtD
Rescinnamine—Hypoaesthesia—Citalopram—alcohol dependence	0.00276	0.00402	CcSEcCtD
Rescinnamine—Pharyngitis—Citalopram—alcohol dependence	0.00275	0.00401	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00269	0.00391	CcSEcCtD
Rescinnamine—Pain—Naltrexone—alcohol dependence	0.00266	0.00387	CcSEcCtD
Rescinnamine—Constipation—Naltrexone—alcohol dependence	0.00266	0.00387	CcSEcCtD
Rescinnamine—Urticaria—Acamprosate—alcohol dependence	0.00261	0.0038	CcSEcCtD
Rescinnamine—Abdominal pain—Acamprosate—alcohol dependence	0.0026	0.00378	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00254	0.0037	CcSEcCtD
Rescinnamine—Urticaria—Naltrexone—alcohol dependence	0.00247	0.0036	CcSEcCtD
Rescinnamine—Abdominal pain—Naltrexone—alcohol dependence	0.00246	0.00358	CcSEcCtD
Rescinnamine—Hypersensitivity—Acamprosate—alcohol dependence	0.00242	0.00353	CcSEcCtD
Rescinnamine—Erythema—Citalopram—alcohol dependence	0.00241	0.00352	CcSEcCtD
Rescinnamine—Dysgeusia—Citalopram—alcohol dependence	0.00236	0.00344	CcSEcCtD
Rescinnamine—Back pain—Citalopram—alcohol dependence	0.00234	0.0034	CcSEcCtD
Rescinnamine—Pruritus—Acamprosate—alcohol dependence	0.00233	0.00339	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—KCNJ6—alcohol dependence	0.00231	0.0329	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Naltrexone—alcohol dependence	0.00229	0.00334	CcSEcCtD
Rescinnamine—Pruritus—Naltrexone—alcohol dependence	0.0022	0.0032	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.00218	0.0311	CbGpPWpGaD
Rescinnamine—Dizziness—Acamprosate—alcohol dependence	0.00217	0.00317	CcSEcCtD
Rescinnamine—Cough—Citalopram—alcohol dependence	0.00211	0.00307	CcSEcCtD
Rescinnamine—Hypertension—Citalopram—alcohol dependence	0.00208	0.00304	CcSEcCtD
Rescinnamine—Rash—Acamprosate—alcohol dependence	0.00207	0.00302	CcSEcCtD
Rescinnamine—Dermatitis—Acamprosate—alcohol dependence	0.00207	0.00302	CcSEcCtD
Rescinnamine—Headache—Acamprosate—alcohol dependence	0.00206	0.003	CcSEcCtD
Rescinnamine—Dizziness—Naltrexone—alcohol dependence	0.00206	0.003	CcSEcCtD
Rescinnamine—Myalgia—Citalopram—alcohol dependence	0.00206	0.00299	CcSEcCtD
Rescinnamine—Discomfort—Citalopram—alcohol dependence	0.00203	0.00296	CcSEcCtD
Rescinnamine—Oedema—Citalopram—alcohol dependence	0.00197	0.00287	CcSEcCtD
Rescinnamine—Rash—Naltrexone—alcohol dependence	0.00196	0.00286	CcSEcCtD
Rescinnamine—Dermatitis—Naltrexone—alcohol dependence	0.00196	0.00285	CcSEcCtD
Rescinnamine—Infection—Citalopram—alcohol dependence	0.00196	0.00285	CcSEcCtD
Rescinnamine—Nausea—Acamprosate—alcohol dependence	0.00195	0.00284	CcSEcCtD
Rescinnamine—Headache—Naltrexone—alcohol dependence	0.00195	0.00284	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.00187	0.0267	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.00185	0.0264	CbGpPWpGaD
Rescinnamine—Nausea—Naltrexone—alcohol dependence	0.00185	0.00269	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.0018	0.00261	CcSEcCtD
Rescinnamine—Insomnia—Citalopram—alcohol dependence	0.00178	0.0026	CcSEcCtD
Rescinnamine—Paraesthesia—Citalopram—alcohol dependence	0.00177	0.00258	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—POMC—alcohol dependence	0.00173	0.0247	CbGpPWpGaD
Rescinnamine—Pain—Citalopram—alcohol dependence	0.00169	0.00245	CcSEcCtD
Rescinnamine—Constipation—Citalopram—alcohol dependence	0.00169	0.00245	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—GABRB1—alcohol dependence	0.00167	0.0238	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Citalopram—alcohol dependence	0.00161	0.00235	CcSEcCtD
Rescinnamine—Urticaria—Citalopram—alcohol dependence	0.00157	0.00228	CcSEcCtD
Rescinnamine—Abdominal pain—Citalopram—alcohol dependence	0.00156	0.00227	CcSEcCtD
Rescinnamine—Hypersensitivity—Citalopram—alcohol dependence	0.00145	0.00211	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—GABRA2—alcohol dependence	0.00142	0.0202	CbGpPWpGaD
Rescinnamine—Pruritus—Citalopram—alcohol dependence	0.00139	0.00203	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.00135	0.0192	CbGpPWpGaD
Rescinnamine—Dizziness—Citalopram—alcohol dependence	0.0013	0.0019	CcSEcCtD
Rescinnamine—Rash—Citalopram—alcohol dependence	0.00124	0.00181	CcSEcCtD
Rescinnamine—Dermatitis—Citalopram—alcohol dependence	0.00124	0.00181	CcSEcCtD
Rescinnamine—Headache—Citalopram—alcohol dependence	0.00123	0.0018	CcSEcCtD
Rescinnamine—Nausea—Citalopram—alcohol dependence	0.00117	0.0017	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.00107	0.0152	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.00105	0.0149	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—ALDH2—alcohol dependence	0.00103	0.0147	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000898	0.0128	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000886	0.0126	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000851	0.0121	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIN2B—alcohol dependence	0.000816	0.0116	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC6A3—alcohol dependence	0.000804	0.0115	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000764	0.0109	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000704	0.01	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—MAOA—alcohol dependence	0.000679	0.00967	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000432	0.00616	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000358	0.00509	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—POMC—alcohol dependence	0.000327	0.00465	CbGpPWpGaD
